AFRICAN MALARIA NETWORK TRUST
🇹🇿Tanzania
- Country
- 🇹🇿Tanzania
- Ownership
- Private
- Established
- 2002-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.amanet-trust.org
Safety and Immunogenicity of 30 and 100 µg of GMZ2 in Gabonese Children Aged 1-5 Years
Phase 1
- Conditions
- Malaria
- Interventions
- Biological: GMZ 2 vaccine (GLURP + MSP 3)Biological: Rabies vaccine
- First Posted Date
- 2008-06-23
- Last Posted Date
- 2008-11-25
- Lead Sponsor
- African Malaria Network Trust
- Target Recruit Count
- 30
- Registration Number
- NCT00703066
- Locations
- 🇬🇦
Medical Research Unit, Albert Schweitzer Hospital, Lambarene, Gabon
Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine
Phase 2
- Conditions
- Malaria
- Interventions
- Biological: MSP3 Long Synthetic Peptide 30 micrograms of MSP3 LSPBiological: Verorab vaccine
- First Posted Date
- 2008-04-03
- Last Posted Date
- 2008-05-07
- Lead Sponsor
- African Malaria Network Trust
- Target Recruit Count
- 378
- Registration Number
- NCT00652275
- Locations
- 🇲🇱
Malaria Research Training Center, Bamako, Mali
Phase Ib Trial of MSP3 LSP in Children in Tanzania
Phase 1
- Conditions
- Malaria
- Interventions
- Biological: MSP3 vaccineBiological: Hepatitis B vaccineBiological: MSP 3 Long Synthetic PeptideBiological: Hepatitis B control vaccineBiological: MSP3 candidate vaccine
- First Posted Date
- 2007-05-04
- Last Posted Date
- 2007-12-14
- Lead Sponsor
- African Malaria Network Trust
- Target Recruit Count
- 45
- Registration Number
- NCT00469651
- Locations
- 🇹🇿
Kwashemshi village, Korogwe, Tanga, Tanzania
A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso
Phase 1
- Conditions
- Malaria
- Interventions
- Biological: Hepatitis B vaccineBiological: MSP 3 Long Synthetic PeptideBiological: Hepatitis B control vaccince
- First Posted Date
- 2007-03-26
- Last Posted Date
- 2008-05-07
- Lead Sponsor
- African Malaria Network Trust
- Target Recruit Count
- 45
- Registration Number
- NCT00452088
- Locations
- 🇧🇫
Projet de Développement de Vaccins Anti-Paludique- Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Sapone, Burkina Faso
Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])
Phase 1
- Conditions
- Malaria
- Interventions
- Biological: Malaria vaccine AMA1 (PfAMA-1-FVO[25-545]Biological: AMA1
- First Posted Date
- 2007-02-06
- Last Posted Date
- 2008-04-03
- Lead Sponsor
- African Malaria Network Trust
- Target Recruit Count
- 40
- Registration Number
- NCT00431808
- Locations
- 🇲🇱
Malaria Research and Training Center, Bandiagara, Mali
Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine
Phase 1
- Conditions
- Malaria
- Interventions
- Biological: GMZ2 (malaria vaccine)Biological: GMZ2 malaria vaccineBiological: Verorab vaccine
- First Posted Date
- 2007-01-22
- Last Posted Date
- 2008-04-03
- Lead Sponsor
- African Malaria Network Trust
- Target Recruit Count
- 40
- Registration Number
- NCT00424944
- Locations
- 🇬🇦
Medical Research Unit, Albert Schweitzer Hospital, Lambarene, Gabon
© Copyright 2025. All Rights Reserved by MedPath